Find trials
Search tips

Analysis of Tumor and Immune Cells Isolated from Tissue and Urine of Bladder Cancer Patients

Overview

About this study

The purpose of this study is to optimize methods in order to analyze immune cell profile in tissue and urine of bladder cancer patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  1. Age ≥ 18 years.
  2. Diagnosis of UC of the bladder, with:
    1. Histologic confirmation of primary UC pathology
    2. Indication for RC
    3. Ineligibility for platinum-based neoadjuvant chemotherapy
  3. Ability to provide informed consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Bradley Leibovich, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20399891

Mayo Clinic Footer